Search results
NCI-MATCH Precision Medicine Clinical Trial
National Cancer Institute· 2 days agoNCI-MATCH, also known as MATCH, is a precision medicine cancer treatment clinical trial that sought to find out if treating cancer based on specific...
Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal...
Centers for Disease Control and Prevention· 1 day agoWe describe an underrecognized Scedosporium spp. and Lomentospora prolificans vascular tropism requiring specific management of which clinicians should be aware.
Ayala Pharmaceuticals (NASDAQ:ADXS) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 6 days agoStockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report issued on Saturday. The firm issued a sell rating on the stock. Ayala Pharmaceuticals ...
Nicklaus Children’s and FIU Collaborate on Groundbreaking Cancer Research That is Saving Lives
Miami Herald via Yahoo News· 6 days agoDiscover how Nicklaus Children’s Hospital is leading the way in pediatric brain cancer care,...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 2 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
MD Anderson Research Highlights: ASCO 2024 Special | Newswise
Newswise· 2 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) Target Price at $27.94
ETF DAILY NEWS· 3 days agoKura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat.com reports.
U.S. Senator Amy Klobuchar’s Bipartisan Bills to Support First Responders Pass the Senate Judiciary...
Sierra Sun Times· 6 days agoMay 19, 2024 - WASHINGTON - Last week, U.S. Senator Amy Klobuchar (D-MN), a member of the Senate...
Brookline Capital Management Brokers Raise Earnings Estimates for Syros Pharmaceuticals, Inc....
ETF DAILY NEWS· 6 days agoSyros Pharmaceuticals, Inc. (NASDAQ:SYRS – Free Report) – Brookline Capital Management boosted their FY2025 EPS estimates for shares of Syros Pharmaceuticals in a note issued to investors on ...
The 3 Best Machine Learning Stocks to Quadruple Your Money by 2035
InvestorPlace· 2 days agoOne of the hottest investment trends to jump on at the moment is machine learning stocks to buy. Along the way, machines will learn from historical data, identify patterns, and make logical ...
